557 results on '"Schmid, Kurt W."'
Search Results
2. Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus TrametinibTumor B-Cell Role in Outcome With Dabrafenib + Trametinib
3. Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
4. Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial
5. An Animal Model Further Uncovers the Role of Mutant BrafV600E during Papillary Thyroid Cancer Development
6. The mismatch repair system is not affected in medullary thyroid carcinoma independent of stromal desmoplasia or ret proto-oncogene mutation
7. Differentiating Benign from Malignant Adrenocortical Tumors by a Single Morphological Parameter—a Clinicopathological Study on 837 Adrenocortical Neoplasias
8. HDAC Inhibition Induces PD-L1 Expression in a Novel Anaplastic Thyroid Cancer Cell Line
9. MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
10. Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
11. High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
12. Supplementary Tables from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
13. Supplementary Data from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
14. Supplementary Figures from Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib
15. Papilloma of the Fallopian Tube: A Rare Gynecologic Neoplasm Harboring a BRAF (c.1799T>A) Mutation (V600E)
16. Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer
17. Optimisation of the Chicken Chorioallantoic Membrane Assay in Uveal Melanoma Research
18. Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting
19. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer
20. Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer
21. Post-Chernobyl Pediatric Papillary Thyroid Carcinoma in Belarus
22. List of Contributors
23. ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural Mesothelioma
24. Head and neck paragangliomas: clinical and molecular genetic classification
25. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use
26. Dissecting Molecular Events in Thyroid Neoplasia Provides Evidence for Distinct Evolution of Follicular Thyroid Adenoma and Carcinoma
27. Optimisation of the Chicken Chorioallantoic Membrane Assay in Uveal Melanoma Research
28. Age, ATA risk group and response to therapy are prognostic factors in children with differentiated thyroid cancer
29. Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study
30. Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
31. Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
32. Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer
33. Regulation of hematogenous tumor metastasis by acid sphingomyelinase
34. German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors
35. Electrochemotherapy with Bleomycin Enhances Radiosensitivity of Uveal Melanomas: First In Vitro Results in 3D Cultures of Primary Uveal Melanoma Cell Lines
36. Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
37. BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy
38. Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus Trametinib.
39. Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas
40. Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis
41. Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE)
42. German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease
43. MET overexpressing chordomas frequently exhibit polysomy of chromosome 7 but no MET activation through sarcoma-specific gene fusions
44. Posterior Retroperitoneoscopic Adrenalectomy for Clinical and Subclinical Cushing’s Syndrome
45. Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas
46. Initial Presentation and Late Results of Treatment of Post-Chernobyl Papillary Thyroid Carcinoma in Children and Adolescents of Belarus
47. Expression of the Transcription Factor Snail and Its Target Gene Twist Are Associated with Malignancy in Pheochromocytomas
48. Evaluation of 47 Soft Tissue Sarcoma Resection Specimens after Isolated Limb Perfusion with TNF-α and Melphalan: Histologically Characterized Improved Margins Correlate with Absence of Recurrences
49. Retroperitoneoscopic Adrenalectomy in Conn’s Syndrome Caused by Adrenal Adenomas or Nodular Hyperplasia
50. Follicular Histotypes of Oncocytic Thyroid Carcinomas Do Not Carry Mutations of the BRAF Hot-spot
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.